0001209191-16-136473.txt : 20160810
0001209191-16-136473.hdr.sgml : 20160810
20160810201845
ACCESSION NUMBER: 0001209191-16-136473
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160810
FILED AS OF DATE: 20160810
DATE AS OF CHANGE: 20160810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 521 COTTONWOOD DRIVE, SUITE 100
CITY: MALPITAS
STATE: CA
ZIP: 95035-7404
BUSINESS PHONE: 408-649-7370
MAIL ADDRESS:
STREET 1: 521 COTTONWOOD DRIVE, SUITE 100
CITY: MALPITAS
STATE: CA
ZIP: 95035-7404
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waddill William D.
CENTRAL INDEX KEY: 0001553338
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 161822734
MAIL ADDRESS:
STREET 1: C/O CALITHERA BIOSCIENCES
STREET 2: 343 OYSTER POINT BLVD, SUITE 200
CITY: SO. SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-08-10
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001553338
Waddill William D.
C/O PROTAGONIST THERAPEUTICS, INC.
521 COTTONWOOD DRIVE, SUITE 100
MILPITAS
CA
95035
1
0
0
0
Stock Option (right to buy)
6.09
2026-07-16
Common Stock
12975
D
The option vests over a two-year period, with 1/24th of the shares subject to the option vesting each month following the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.
/s/ William D. Waddill
2016-08-08
EX-24.3_670529
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these present, that the undersigned hereby constitutes and appoints
each of DINESH V. PATEL, PH.D., and THOMAS P. O'NEIL, signing individually, the
undersigned's true and lawful attorneys-in fact and agents to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director or beneficial owner of more than 10% of a registered
class of securities of Protagonist Therapeutics, Inc. (the "Company"), (a) Forms
3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a)
of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the
rules thereunder and a (b) Form ID, Uniform Application for Access Codes to File
on EDGAR, including Update Passphrase Confirmation;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to execute such Forms 3, 4 or 5 or Form ID
(including any amendments thereto) and timely file such forms with the United
States Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact is no longer employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of July 8, 2016.
/s/ William D. Waddill
William D. Waddill